| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.69 | 1e-06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.52 | 0.0003 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.54 | 0.0003 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.53 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.55 | 0.0007 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.5 | 0.0009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.52 | 0.001 |